Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

T2 Biosystems Inc (TTOO) USD0.001

Sell:$1.22 Buy:$1.23 Change: $0.005 (0.41%)
Market closed |  Prices as at close on 18 September 2020 | Switch to live prices |
Sell:$1.22
Buy:$1.23
Change: $0.005 (0.41%)
Market closed |  Prices as at close on 18 September 2020 | Switch to live prices |
Sell:$1.22
Buy:$1.23
Change: $0.005 (0.41%)
Market closed |  Prices as at close on 18 September 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

T2 Biosystems, Inc. is an in vitro diagnostics company engaged in developing a technology platform offering an alternative to diagnostic methodologies. The Company's T2 Magnetic Resonance platform (T2MR) enables detection of pathogens, biomarkers and other abnormalities in a range of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as one colony forming unit per milliliter (CFU/mL). The Company's initial development efforts target sepsis, hemostasis and Lyme disease. T2MR is a miniaturized, magnetic resonance-based approach that measures how water molecules react in the presence of magnetic fields. Its platform detects a range of targets, including molecular targets, such as deoxyribonucleic acid (DNA), immunodiagnostics, such as proteins, and a range of hemostasis measurements. The Company offers T2Dx Instrument (T2Dx) and the T2Candida Panel.

Contact details

Address:
101 Hartwell Ave
LEXINGTON
02421-3125
United States
Telephone:
+1 (781) 4571200
Website:
www.t2biosystems.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
TTOO
ISIN:
US89853L1044
Market cap:
$187.90 million
Shares in issue:
147.95 million
Sector:
Biotechnology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • John Sperzel
    President, Chief Executive Officer, Director
  • John Sprague
    Chief Financial Officer
  • Alec Barclay
    Chief Operating Officer
  • Thomas Lowery
    Chief Scientific Officer
  • Michael Gibbs
    Vice President, General Counsel
  • Anthony Pare
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.